We observed that single high-dose RT upregulated CD25 on intratumoral CD8+ T cells, which facilitated the combination of RT with a CD25-biased IL-2cx, resulting in efficient reduction of both primary irradiated and abscopal tumor nodules. The gene discussed is CD8A; the disease is neoplasm.